NatWest Rises, GSK Drops, Accor Up
On this episode of Stock Movers:- NatWest raised its guidance for the year after beating estimates in the 3Q, delivering its highest earnings in at least a decade.- GSK shares dropped as approval of the British pharma company’s blood cancer drug for a later-than-expected treatment line raised concerns about the medicine’s sales potential.- Accor shares rose after 3Q earnings in which the hotelier raised its guidance on the back of improved cost discipline. It also announced a new €100 million buyback in 4Q.See omnystudio.com/listener for privacy information.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.